Fidelta, a collaborative drug discovery company, has appointed Dr Adrijana Vinter, current head of business development, as new managing director of the company.
Adrijana will commence her new role from January 1st 2017, succeeding Dr Phil Dudfield who is retiring.
Adrijana obtained her PhD in Chemistry at the University of Zagreb in the field of new macrolide antibiotics and started her career in PLIVA 14 years ago working initially as a scientist. She obtained an MBA at Cotrugli Business School, Croatia, before moving into Business Development with the creation of Fidelta. She has successfully engineered and overseen the development of the Fidelta revenue stream resulting in significant year on year growth.
Under the new leadership, Fidelta’s operations will continue seamlessly through delivering high quality services to the clients.
Please find attached related press release.